Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Liabilities and Shareholders Equity: 2011-2012

Historic Liabilities and Shareholders Equity for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to $7.8 million.

  • Sonoma Pharmaceuticals' Liabilities and Shareholders Equity rose 31.72% to $11.8 million in Q4 2012 from the same period last year, while for Dec 2012 it was $42.8 million, marking a year-over-year increase of 23.50%. This contributed to the annual value of $7.8 million for FY2012, which is 9.53% down from last year.
  • Latest data reveals that Sonoma Pharmaceuticals reported Liabilities and Shareholders Equity of $7.8 million as of FY2012, which was down 9.53% from $8.7 million recorded in FY2011.
  • Sonoma Pharmaceuticals' 5-year Liabilities and Shareholders Equity high stood at $8.7 million for FY2011, and its period low was $7.8 million during FY2012.
  • Moreover, its 2-year median value for Liabilities and Shareholders Equity was $8.3 million (2011), whereas its average is $8.3 million.
  • Data for Sonoma Pharmaceuticals' Liabilities and Shareholders Equity shows a maximum YoY decreased of 9.53% (in 2012) over the last 5 years.
  • Over the past 2 years, Sonoma Pharmaceuticals' Liabilities and Shareholders Equity (Yearly) stood at $8.7 million in 2011, then fell by 9.53% to $7.8 million in 2012.